- Aadhaar card
- Driving License
- PAN card
- Pension Passbook
- NPR Smart Card
- Voter ID (EPIC)
- One type of vaccine will be provided at such sessions that are conducted at the Work Places. This is necessary to avoid mixing of vaccine types in 1st and 2nd dose of a beneficiary.
- Beneficiaries at the Workplace who have already received one dose of a vaccine different from the one being administered at the WorkPlace CVC shall not be vaccinated at session in the WorkPlace CVC. They are expected to get the second dose of the same vaccine at an appropriate COVID vaccination centre. However, those who have received same a vaccine as first dose may be provided as the second dose at the WorkPlace CVC.
- The full list of beneficiaries, as available in Co-WIN, will be visible to all verifiers and vaccinators, option of on-the-spot registration will also be available.
- Verification will be done by Verifier (Vaccination Officer-1) preferably using Aadhar.
- In case Aadhar authentication is not possible for any reason, the Verifier will verify the identity and eligibility of the beneficiary from the photo ID Card indicated by the beneficiary at the time of registration.
- Apart from Aadhar, other IDs approved by the MoHFW are:
- Driving license,
- PAN Card,
- Smart Card issued by RGI under NPR,
- Pension Document with Photograph.
- If the identity and eligibility of a beneficiary is established upon verification, the beneficiary will be vaccinated and his/her vaccination status will be updated, else the the beneficiary will not be vaccinated.
- All Vaccination must be recorded in real time through the Co-WIN Vaccinator Module on the same day.
- The digital vaccination certificate of the beneficiary will be generated through Co-WIN, Workplace CVC Nodal Person will be responsible for providing a printed copy of the vaccination certificate, both after 1st and 2nd doses, to the beneficiary, on site after vaccination.
- Operational guidelines and standard operating procedure for COVID-19 vaccination should be referred for detailed planning and operationalization.
These are available at
- COVID 19 vaccination at government Workplace organized by district health authorities will be free of cost.
- COVID 19 vaccination organized by private CVC would be on payment basis and will be at same rate as of vaccination at private health facilities.
- Service charge subject to a ceiling of INR 100 /- per person per dose,
- Vaccine cost INR 150/- per person per dose.
- Hence, the financial ceiling of the total amount recoverable by private health facility is INR 250/- per person per dose.
- • The Private health facility that will be organizing vaccination at the private sector Workplace.will deposit the cost of vaccines upfront in the bank account designated by the National HealthAuthority. The hospitals will provide proof of payments to the DIO in-charge of the concerned district. The payment gateway on the NHA portal will be used by the private CVC for this purpose.
- The District Task Force (DTF) chaired by District Magistrate and Urban Task Force (UTF) chaired by Municipal Commissioner will identify such government and private Workplaces after due deliberations with relevant employers and / or Head of offices.
- Workplace management will designate one of their senior staff to work as “Nodal Officer'' to coordinate with district health authorities/ private COVID Vaccination Centres (CVCs) and support vaccination activities.
- The Nodal Officer will oversee and facilitate all aspects of vaccination at Work Place CVC like registration of beneficiaries, availability of physical and IT infrastructure and oversight to vaccination etc.
- Only employees of WorkPlace aged 45 years or more will be eligible for vaccination at Work Place, no outsiders including eligible family members will be allowed for vaccination at "CVC at Work Place".
- Beneficiaries must be registered in the Co-WIN portal prior to vaccination. CVC Nodal Officer will ensure registration of all targeted beneficiaries and facility of on-the spot registration will also be available but only to employees of the workplace.
- Helpline Number: +91-11-23978046 (Toll free- 1075)
- Technical Helpline Number: 0120-4473222
- Helpline Email Id: email@example.com
It has been called a ‘variant of concern’ by the US CDC. WHO has said that it has spread to over 80 countries.
Considering the rapid mutation of the original Sars-CoV-2 virus, which led to the spread of the coronavirus disease, it is very important now to get yourself vaccinated. The second wave of the pandemic, led by the Delta variant, showed how rapidly the infection was spreading. It also caused a high number of fatalities.
Researchers at Pune’s Indian Council of Medical Research-National Institute of Virology (ICMR-NIV) Bharat Biotech’s Covaxin is also effective in neutralising the Delta and Beta variants of Sars-CoV-2.
However, a study conducted by Delhi's All India Institute of Medical Sciences (AIIMS) said that the Delta variant can infect vaccinated people, though the infection does not become severe. This makes it even more important to take the jab as soon as possible. .
Vinod Scaria, clinician and scientist at Delhi’s CSIR-Institute of Genomics and Integrative Biology (IGIB), said on Twitter that the new mutation is characterised by the acquisition of K417N mutation. It is the spike protein of Sars-CoV-2, which helps the virus enter and infect the human cells, he added.
According to Public Health England, 63 genomes of Delta variant with the new K417N mutation have been identified so far on the global science initiative GISAID. However, in India, its incidence is still low.
Therefore, one can assume that there would be some immunological benefit for those who suffered the disease with a symptomatic infection.
He said at a press conference that there is no need to panic. "We must remember that when we increased the gap, we had to consider the risk posed by the virus to those who have received only one dose. But the counterpoint was that more people will then be able to get the first dose, thereby giving a reasonable degree of immunity to more people."
- Physical distancing, indoor mask use, strict hand hygiene.
- Symptomatic management (hydration, antipyretics, antitussive, multivitamins).
- Stay in contact with a treating physician.
- Monitor temperature and oxygen saturation (by applying a SpO2 probe to fingers). Seek immediate medical attention if:
- Difficulty in breathing
- High grade fever/severe cough, particularly if lasting for >5 days
- A low threshold to be kept for those with any of the high-risk features*
Therapies based on low certainty of evidence
- Tab Ivermectin (200 mcg/kg once a day for 3 days). Avoid for pregnant and lactating women.
- Tab HCQ (400 mg BD for 1 day f/b 400 mg OD for 4 days) unless contraindicated. Inhalational Budesonide (given via Metered dose inhaler/ Dry powder inhaler) at a dose of 800 mcg BD for 5 days) to be given if symptoms (fever and/or cough) are persistent beyond 5 days of disease onset.
- The patient should be clinically assigned as mild/ asymptomatic case by the treating Medical Officer.
- Such cases should have the requisite facility at their residence for self-isolation and for quarantining the family contacts.
- A care giver should be available to provide care on 24 x7 basis. A communication link between the caregiver and hospital is a prerequisite for the entire duration of home isolation.
- Elderly patients aged more than 60 years and those with co-morbid conditions such as Hypertension, Diabetes, Heart disease, Chronic lung/liver/ kidney disease, Cerebro-vascular disease etc shall only be allowed home isolation after proper evaluation by the treating medical officer.
- Patients suffering from immune compromised status (HIV, Transplant recipients, Cancer therapy etc.) are not recommended for home isolation and shall only be allowed home isolation after proper evaluation by the treating medical officer.
- The care giver and all close contacts of such cases should take Hydroxychloroquine prophylaxis as per protocol and as prescribed by the treating medical officer.
- In addition, the guidelines on home-quarantine for other members available at:
- https://www.mohfw.gov.in/pdf/Guidelinesforhomequarantine.pdf, shall be also followed.
- Patient must isolate himself from other household members, stay in the identified room and away from other people in home, especially elderlies and those with co-morbid conditions like hypertension, cardiovascular disease, renal disease etc.
- The patient should be kept in a well-ventilated room with cross ventilation and windows should be kept open to allow fresh air to come in.
- Patient should at all times use triple layer medical mask. Discard mask after 8 hours of use or earlier if they become wet or visibly soiled. In the event of care giver entering the room, both care giver and patient may consider using N 95 mask.
- Mask should be discarded only after disinfecting it with 1% Sodium Hypochlorite.
- Patient must take rest and drink lot of fluids to maintain adequate hydration.
- Follow respiratory etiquettes at all times.
- Frequent hand washing with soap and water for at least 40 seconds or clean with alcohol-based sanitizer.
- Don’t share personal items with other people in the household.
- Ensure cleaning of surfaces in the room that are touched often (tabletops, doorknobs, handles, etc.) with 1% hypochlorite solution.
- Self-monitoring of blood oxygen saturation with a pulse oximeter is strongly advised.
- The patient will self-monitor his/her health with daily temperature monitoring and report promptly if any deterioration of symptom as given below is noticed.
- The caregiver should wear a triple layer medical mask. N95 mask may be considered when in the same room with the ill person.
- Front portion of the mask should not be touched or handled during use.
- If the mask gets wet or dirty with secretions, it must be changed immediately.
- Discard the mask after use and perform hand hygiene after disposal of the mask.
- He/she should avoid touching own face, nose or mouth.
- Hand hygiene
- Hand hygiene must be ensured following contact with ill person or his immediate environment.
- Hand hygiene should also be practiced before and after preparing food, before eating, after using the toilet, and whenever hands look dirty.
- Use soap and water for hand washing at least for 40 seconds. Alcohol-based hand rub can be used, if hands are not visibly soiled.
- After using soap and water, use of disposable paper towels to dry hands is desirable. If not available, use dedicated clean cloth towels and replace them when they become wet.
- Perform hand hygiene before and after removing gloves.
- Exposure to patient/patient’s environment
- Avoid direct contact with body fluids of the patient, particularly oral or respiratory secretions. Use disposable gloves while handling the patient.
- Avoid exposure to potentially contaminated items in his immediate environment (e.g. avoid sharing cigarettes, eating utensils, dishes, drinks, used towels or bed linen).
- Food must be provided to the patient in his room. Utensils and dishes used by the patient should be cleaned with soap/detergent and water wearing gloves. The utensils and dishes may be re-used.
- Clean hands after taking off gloves or handling used items. Use triple layer medical mask and disposable gloves while cleaning or handling surfaces, clothing or linen used by the patient.
- Perform hand hygiene before and after removing gloves.
- Biomedical Waste disposal
- Effective waste disposal shall be ensured so as to prevent further spread of infection within household. The waste (masks, disposable items, food packets etc.) should be disposed of as per CPCB guidelines (available at:
- Patients must be in communication with a treating physician and promptly report in case of any deterioration.
- Continue the medications for other co-morbid illness after consulting the treating physician.
- Patients to follow symptomatic management for fever, running nose and cough, as warranted.
- Patients may perform warm water gargles or take steam inhalation twice a day.
- If fever is not controlled with a maximum dose of Tab. Paracetamol 650mg four times a day, consult the treating doctor who may consider advising other drugs like non-steroidal anti-inflammatory drug (NSAID) (ex: Tab. Naproxen 250 mg twice a day).
- The decision to administer Remdesivir or any other investigational therapy must be taken by a medical professional and administered only in a hospital setting. Do not attempt to procure or administer Remdesivir at home.
- Systemic oral steroids not indicated in mild disease. If symptoms persist beyond 7 days (persistent fever, worsening cough etc.) consult the treating doctor for treatment with low dose oral steroids.
- In case of falling oxygen saturation or shortness of breath, the person should require hospital admission and seek immediate consultation of their treating physician/surveillance team.
- Patient / Care giver will keep monitoring their health. Immediate medical attention must be sought if serious signs or symptoms develop. These could includei. Difficulty in breathing,
- Dip in oxygen saturation (SpO2 < 94% on room air)
- Persistent pain/pressure in the chest,
- Mental confusion or inability to arouse,
- States/ Districts should monitor all cases under home isolation.
- The health status of those under home isolation should be monitored by the field staff/surveillance teams through personal visit along with a dedicated call centre to follow up the patients on daily basis.
- The clinical status of each case shall be recorded by the field staff/call centre (body temperature, pulse rate and oxygen saturation). The field staff will guide the patient on measuring these parameters and provide the instructions (for patients and their care givers). This mechanism to daily monitor those under home isolation shall be strictly adhered to.
- Details about patients under home isolation should also be updated on COVID-19 portal and facility app (with DSO as user). Senior State and District officials should monitor the records updation. v. A mechanism to shift patient in case of violation or need for treatment has to be established and implemented. Sufficient dedicated ambulances for the same shall be organised. Wide publicity for the same shall also be given to the community.
- All family members and close contacts shall be monitored and tested as per protocol by the field staff.
- Patient on home isolation will be discharged from treatment as indicate above. These discharge guidelines shall be strictly adhered to.
- Deep venous thrombosis (Treated in less than 48 hours)
- Major cardiac conditions
- Using a flat sheet, pull the patient to one side of the bed.
- Place the flat sheet around the arm that will pull through (the side you are turning toward).
- A second flat sheet is placed on the bed and tucked under the patient. This sheet will pull through as you are turning the patient.
- Using the sheet, turn the patient over and position the patient prone. The arm and sheet will pull across the bed.
- Pull and center the patient. Discard the sheet that was used to place the patient in the supine position. Straighten lines and tubes.
Clinical Features:Majority of children with covid infection may be asymptomatic or mildly symptomatic. Common symptoms include- fever, cough, breathlessness/ shortness of breath, fatigue, myalgia, rhinorrhea, sore throat, diarrhea, loss of smell, loss of taste etc. Few children may present with gastrointestinal symptoms and atypical symptoms. A new syndrome with name of multi system inflammatory syndrome has been described in children. Such cases are characterized by: unremitting fever > 38oC, epidemiological linkage with SARS CoV – 2 and clinical features suggestive of Multi System Inflammatory Syndrome.
- There is requisite facility for isolation at his/her residence and also for quarantining the family contacts
- Parents or other care taker who can monitor and take care of child
- If available, Arogya Setu App should be downloaded
- The parents/care giver has agreed to monitor health of the child and regularly inform his/her health status to the Surveillance Officer/ doctor
- The parents/ care giver has filled an undertaking on self-isolation and shall follow home isolation/quarantine guidelines
Children with moderate Covid – 19 disease should be administered:
- For fever: Paracetamol 10-15 mg/kg/dose. May be repeated every 4-6 hourly. (temperature > 38oC, i.e. 100.4oF).
- Amoxycillin to be administered, if there is evidence/ strong suspicion of bacterial infection.
- For SpO2 below 94%, oxygen supplementation is required.
- Corticosteriods may be administered in rapidly progressive disease. It is not required in all children with moderate illness, specifically during first few days of illness.
- Supportive care for comorbid conditions, if any.
- Crystalloid bolus administration: 10 to 20 ml/kg over 30 to 60 minutes; be cautious if cardiac dysfunction is there.
- Early inotrope support with monitoring of fluid overload like any other cause of shock.
A new syndrome with name of multisystem inflammatory syndrome as been described in children. Such cases are characterized by: unremitting fever > 380 C, epidemiological linkage with SARS CoV – 2 and clinical features suggestive of Multi System Inflammatory Syndrome.
Diagnostic criteria of MISC in Children (WHO criteria): a constellation of clinical and laboratory parameters has been suggested for diagnosis. These include:
Children and adolescents 0–19 years of age with fever ≥ 3 days
AND two of these:
- Rash or bilateral non-purulent conjunctivitis or muco-cutaneous inflammation signs (oral, hands or feet).
- Hypotension or shock.
- Features of myocardial dysfunction, pericarditis, valvulitis, or coronary abnormalities (including ECHO findings or elevated Troponin/NT- proBNP),
- Evidence of coagulopathy (by PT, PTT, elevated d-Dimers).
- Acute gastrointestinal problems (diarrhoea, vomiting, or abdominal pain). AND
- Elevated markers of inflammation such as ESR, C-reactive protein, or procalcitonin. AND
- No other obvious microbial cause of inflammation, including bacterial sepsis, staphylococcal or streptococcal shock syndromes.
- Evidence of COVID-19 (RT-PCR, antigen test or serology positive), or likely contact with patients with COVID-19.
- Dry cough
- Loss of taste or smell,
- Nasal congestion,
- Conjunctivitis (also known as red eyes)
- Sore throat,
- Muscle or joint pain,
- Different types of skin rash,
- Nausea or vomiting,
- Chills or dizziness.
- Shortness of breath,
- Loss of appetite,
- Persistent pain or pressure in the chest,
- High temperature (above 38 °C).
- Reduced consciousness (sometimes associated with seizures),
- Sleep disorders,
- More severe and rare neurological complications such as strokes, brain inflammation, delirium and nerve damage.
People of all ages who experience fever and/or cough associated with difficulty breathing or shortness of breath, chest pain or pressure, or loss of speech or movement should seek medical care immediately. If possible, call your health care provider, hotline or health facility first, so you can be directed to the right clinic.
Masks are a key measure to suppress transmission and save lives.Masks are a key measure to suppress transmission and save lives. Masks should be used as part of a comprehensive ‘Do it all!’ approach including physical distancing, avoiding crowded, closed and close-contact settings, good ventilation, cleaning hands, covering sneezes and coughs, and more. Depending on the type, masks can be used for either protection of healthy persons or to prevent onward transmission.
- Health workers in clinical settings. See WHO guidance for more information on the use of personal protective equipment by health care workers
- Anyone who is feeling unwell, including people with mild symptoms, such as muscle aches, slight cough, sore throat or fatigue.
- Anyone awaiting COVID-19 test results or who has tested positive.
- People caring for someone who is a suspected or confirmed case of COVID-19 outside of health facilities.
- People aged 60 or over.
- People of any age with underlying health conditions, including chronic respiratory disease, cardiovascular disease, cancer, obesity, immunocompromised patients and diabetes mellitus.
- Inner layer of absorbent material, such as cotton.
- Middle layer of non-woven non-absorbent material, such as polypropylene.
- Outer layer of non-absorbent material, such as polyester or polyester blend.
- Clean your hands before taking off the mask.
- Take off the mask by removing it from the ear loops, without touching the front of the mask.
- If your fabric mask is not dirty or wet and you plan to reuse it, put it in a clean plastic, resealable bag. If you need to use it again, hold the mask at the elastic loops when removing it from the bag. Clean your mask once a day.
- Clean your hands after removing the mask.
- Wash fabric masks in soap or detergent and preferably hot water (at least 60 degrees Centigrade/140 degrees Fahrenheit) at least once a day.
- If it is not possible to wash the mask in hot water, then wash it in soap/detergent and room temperature water, followed by boiling the mask for 1 minute.
- Make sure to clean your hands before touching your mask.
- Make sure you have your own mask and do not share it with others.
- Resist the temptation to pull down your mask to your chin or take if off when speaking to other people.
- Do not store your mask around your arm or wrist or pull it down to rest around your chin or neck. Instead, store it in a clean plastic bag.
- composed of 3 layers of synthetic nonwoven materials
- configured to have filtration layers sandwiched in the middle
- available in different thicknesses
- have various levels of fluid-resistance and filtration
- Health workers and caregivers include: doctors, nurses, midwives, medical attendants, cleaners, community health workers, and any others working in clinical areas.
- Health workers must remember to combine hand hygiene with any time they touch their mask or face, before and after putting on and removing their masks, as well as before they touch them to readjust them.